Endospan’s Aortic Arch-Repair System Gets Breakthrough Designation

The FDA has granted Endospan a Breakthrough Device designation for its NEXUS stent graft system for aortic arch repairs.

The device is designed to enable a minimally invasive procedure via small blood vessels in the arm or groin, reducing recovery time.

The system allows physicians to repair the aortic arch from inside the aorta, removing the need to open the patient’s chest or cut their aorta.